Page 66 - Micro5 Brochure 2017

Abstract
PURPOSE:
Wound care in a rehabilitation environment is a costly and difficult problem. The goal of this retrospective
study is to evaluate differences in wound closure outcomes in acute and chronic wounds when treated
with a microcurrent-generating wound care device as compared to standard wound care methods.

METHODS:
Data files of 38 patients who received either standard wound treatment (SOC; n = 20), or were treated
with a microcurrent-generating wound device (MCD, n = 18), were retrospectively reviewed. Wounds
were assessed until deemed clinically to have closed or healed with up to 100% epithelialization. All
patients (18-99 years) with single wounds were included. The number of days to wound closure and the
rate of wound volume reduction were compared across groups. Persistent reduction of wound size
improvement was also examined.

RESULTS:
The wounds in the SOC group closed on average at 36.25 days (SD = 28.89), while the MCD group
closed significantly faster in 19.78 days (SD = 14.45), p = 0.036. The rate of volume reduction per day
was -3.83% for SOC vs. -9.82% volume reduction per day (p = 0.013) for the MCD group. The SOC
group had 50% of its wounds close monotonically vs. 83.3% in the MCD group (p = 0.018).

CONCLUSION:
This two-center retrospective study demonstrated a 45.4% faster, and more robust healing of wounds
with the use of the MCD, when compared to SOC in a rehabilitation center environment. This translates
into improved patient care, and potentially significant cost savings. Economic benefits for the use of MCD
compared to other wound care methods are planned for future research.

hysiother Res Int. 2012 Sep;17(3):157-66. doi: 10.1002/pri.526. Epub 2011 Dec 7.

Microcurrent therapy in the management of chronic tennis elbow:
pilot studies to optimize parameters.

Poltawski L1, Johnson M, Watson T.
Author information
Abstract
BACKGROUND AND PURPOSE:
In microcurrent therapy (MCT), low-intensity electric current is applied to promote tissue healing and
relieve symptoms. MCT is used with recalcitrant skin and bone lesions, but little is known about its effects
on tendinopathy, and optimal treatment parameters are uncertain. Two studies were conducted to
ascertain whether varying (i) current intensity and (ii) waveform and treatment duration affect outcomes of
MCT for chronic tennis elbow.

METHODS:
Two trials compared the effects of different MCT parameters on pain and function, grip strength, and
sonographically graded tendon structure and hyperaemia. Trial 1 compared monophasic MCT of intensity
50 and 500 μA applied for 35 h; trial 2 compared devices delivering approximately 25 μA but with different